Ana Carolina Proença da Fonseca1, Claudio Mastronardi2, Angad Johar3, Mauricio Arcos-Burgos2, Gilberto Paz-Filho4. 1. Human Genetic Laboratory, Oswaldo Cruz Institute/FIOCRUZ, Rio de Janeiro, Brazil. 2. Institute of Translational Medicine, Universidad del Rosario, Bogota, Colombia. 3. Department of Genome Sciences, John Curtin School of Medical Research, The Australian National University, Australia. Electronic address: u4842377@anu.edu.au. 4. Department of Genome Sciences, John Curtin School of Medical Research, The Australian National University, Australia. Electronic address: gilberto.pazfilho@anu.edu.au.
Abstract
BACKGROUND: Childhood obesity is a serious public health problem associated with the development of several chronic diseases, such as type 2 diabetes mellitus, dyslipidemia, and hypertension. The elevated prevalence of obesity is mostly due to inadequate diet and lifestyle, but it is also influenced by genetic factors. OBJECTIVES: To review recent advances in the field of the genetics of obesity. We summarize the list of genes associated with the rare non-syndromic forms of obesity, and explain their function. Furthermore, we discuss the technologies that are available for the genetic diagnosis of obesity. RESULTS: Several studies reported that single gene variants cause Mendelian forms of obesity, determined by mutations of major effect in single genes. Rare, non-syndromic forms of obesity are a result of loss-of-function mutations in genes that act on the development and function of the hypothalamus or the leptin-melanocortin pathway. These variants disrupt enzymes and receptors that play a role in energy homeostasis, resulting in severe early-onset obesity and endocrine dysfunctions. Different approaches and technologies have been used to understand the genetic background of obesity. Currently, whole genome and whole exome sequencing are important diagnostic tools to identify new genes and variants associated with severe obesity, but other approaches are also useful at individual or population levels, such as linkage analysis, candidate gene sequencing, chromosomal microarray analysis, and genome-wide association studies. CONCLUSIONS: The understanding of the genetic causes of obesity and the usefulness and limitations of the genetic diagnostic approaches can contribute to the development of new personalized therapeutic targets against obesity.
BACKGROUND: Childhood obesity is a serious public health problem associated with the development of several chronic diseases, such as type 2 diabetes mellitus, dyslipidemia, and hypertension. The elevated prevalence of obesity is mostly due to inadequate diet and lifestyle, but it is also influenced by genetic factors. OBJECTIVES: To review recent advances in the field of the genetics of obesity. We summarize the list of genes associated with the rare non-syndromic forms of obesity, and explain their function. Furthermore, we discuss the technologies that are available for the genetic diagnosis of obesity. RESULTS: Several studies reported that single gene variants cause Mendelian forms of obesity, determined by mutations of major effect in single genes. Rare, non-syndromic forms of obesity are a result of loss-of-function mutations in genes that act on the development and function of the hypothalamus or the leptin-melanocortin pathway. These variants disrupt enzymes and receptors that play a role in energy homeostasis, resulting in severe early-onset obesity and endocrine dysfunctions. Different approaches and technologies have been used to understand the genetic background of obesity. Currently, whole genome and whole exome sequencing are important diagnostic tools to identify new genes and variants associated with severe obesity, but other approaches are also useful at individual or population levels, such as linkage analysis, candidate gene sequencing, chromosomal microarray analysis, and genome-wide association studies. CONCLUSIONS: The understanding of the genetic causes of obesity and the usefulness and limitations of the genetic diagnostic approaches can contribute to the development of new personalized therapeutic targets against obesity.
Authors: Ana Carolina Proença da Fonseca; Guilherme Proença da Fonseca; Bruna Marchesini; Danielle Dutra Voigt; Mario Campos Junior; Verônica Marques Zembrzuski; João Regis Ivar Carneiro; José Firmino Nogueira Neto; Pedro Hernan Cabello; Giselda Maria Kalil Cabello Journal: Obes Facts Date: 2020-04-23 Impact factor: 3.942
Authors: Jami L Josefson; Patrick M Catalano; William L Lowe; Denise M Scholtens; Alan Kuang; Alan R Dyer; Lynn P Lowe; Boyd E Metzger Journal: J Clin Endocrinol Metab Date: 2020-07-01 Impact factor: 5.958
Authors: Ana Carolina Proença da Fonseca; Gabriella de Medeiros Abreu; Verônica Marques Zembrzuski; Mario Campos Junior; João Regis Ivar Carneiro; Fernanda Cristina C Mattos Magno; Eliane Lopes Rosado; José Firmino Nogueira Neto; Giselda Maria Kalil de Cabello; Pedro Hernán Cabello Journal: Diabetes Metab Syndr Obes Date: 2019-02-21 Impact factor: 3.168
Authors: Kaio Cezar Rodrigues Salum; Guilherme Orofino de Souza; Gabriella de Medeiros Abreu; Mário Campos Junior; Fabiana Barzotto Kohlrausch; João Regis Ivar Carneiro; José Firmino Nogueira Neto; Fernanda Cristina C Mattos Magno; Eliane Lopes Rosado; Lohanna Palhinha; Clarissa Menezes Maya-Monteiro; Giselda Maria Kalil de Cabello; Pedro Hernán Cabello; Patrícia Torres Bozza; Verônica Marques Zembrzuski; Ana Carolina Proença da Fonseca Journal: Front Genet Date: 2020-12-09 Impact factor: 4.599
Authors: Ana Carolina Proença da Fonseca; Gabriella de Medeiros Abreu; Lohanna Palhinha; Verônica Marques Zembrzuski; Mario Campos Junior; João Regis Ivar Carneiro; José Firmino Nogueira Neto; Fernanda Cristina C Mattos Magno; Eliane Lopes Rosado; Clarissa Menezes Maya-Monteiro; Giselda Maria Kalil de Cabello; Pedro Hernán Cabello; Patricia Torres Bozza Journal: Diabetes Metab Syndr Obes Date: 2021-01-06 Impact factor: 3.168
Authors: Petra Loid; Taina Mustila; Riikka E Mäkitie; Heli Viljakainen; Anders Kämpe; Päivi Tossavainen; Marita Lipsanen-Nyman; Minna Pekkinen; Outi Mäkitie Journal: Front Endocrinol (Lausanne) Date: 2020-02-21 Impact factor: 5.555